A U.S. outpatient diagnostic imaging company, RadNet operates roughly four hundred multi-modality centers across nine states, where patients get MRIs, CT scans, PET scans, and mammograms. Founded in 1981 by six Los Angeles doctors (including current CEO Howard Berger), it began by billing for radiology groups before opening its first imaging center across from Cedars-Sinai. Its name blends "radiology" and "network," and its DeepHealth arm builds AI tools for reading scans, born from a 2020 acquisition of a Cambridge mammography-AI startup.
RadNet reports record Q2 2026 revenue and Adjusted EBITDA, raises 2026 guidance
Total Company Revenue increased 25.0% to a quarterly record of $622.7 million in Q2 2026 from $498.2 million in Q2 2025.
Show detailsHide details
Total Company Adjusted EBITDA was a quarterly record of $99.7 million in Q2 2026, up 22.7% from $81.2 million in Q2 2025.
Digital Health segment revenue increased 56.5% to $32.4 million in Q2 2026, with Annual Recurring Revenue (ARR) of $105.5 million as of June 30, 2026.
Unadjusted net income for Q2 2026 was $7.5 million ($0.10 per diluted share), compared with $14.5 million ($0.19 per diluted share) in Q2 2025.
RadNet revised upward its full-year 2026 Imaging Center guidance for Revenue, Adjusted EBITDA, and Free Cash Flow, while reaffirming all Digital Health guidance ranges.
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
RadNet secures $250M incremental term loan and cuts credit facility interest rates by 0.25%
RadNet, Inc. and its subsidiary Radnet Management, Inc. entered into Incremental Amendment No. 3 to its credit agreement on June 10, 2026.
Show detailsHide details
The amendment provides a $250.0 million incremental term loan maturing April 18, 2031, with quarterly principal payments of approximately $3.1 million.
Proceeds are intended for future acquisitions, organic expansion, health system partnerships, and general corporate purposes.
Interest rates on the term loan and the $282 million revolving credit facility were each reduced by 0.25%.
The company provided six months of call protection to lenders participating in the repricing of the existing term loan.
1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
RadNet stockholders elect six directors and approve all four proposals at 2026 Annual Meeting
At the June 2, 2026 Annual Meeting, 73,252,507 shares (93.58% of outstanding) were represented, constituting a quorum.
Show detailsHide details
Stockholders elected six directors: Howard G. Berger, A. Gregory Sorensen, Laura P. Jacobs, Lawrence L. Levitt, Gregory E. Spurlock, and David L. Swartz, each to serve until the 2027 Annual Meeting.
The ratification of Ernst & Young LLP as independent auditor for fiscal year 2026 was approved with 72,890,772 votes for, 346,990 against, and 14,745 abstentions.
The non-binding advisory vote on Named Executive Officer compensation was approved with 61,158,497 votes for, 3,892,047 against, and 82,662 abstentions.
The amendment and restatement of the Equity Incentive Plan was approved with 63,254,838 votes for, 1,844,622 against, and 33,746 abstentions.
5.07 Submission of Matters to a Vote of Security Holders
RadNet proposes $200M incremental term loan to fund strategic growth
On June 3, 2026, RadNet, Inc. announced a proposed $200.0 million incremental term loan under its Third Amended and Restated First Lien Credit and Guaranty Agreement.
Show detailsHide details
The proposed loan would mature on April 18, 2031, matching the existing term loan's maturity date.
Proceeds are expected to finance future acquisitions, organic expansion, health system partnerships, and general corporate purposes.
The transaction is subject to customary market and other conditions, with consummation expected around mid-June 2026.
The press release was furnished as Exhibit 99.1 to the Form 8-K filed under Item 8.01.
8.01 Other Events · 9.01 Financial Statements and Exhibits
RadNet acquires Gleamer for up to €230 million, expanding DeepHealth's radiology AI portfolio.
RadNet, Inc. announced the acquisition of Gleamer SAS, a Paris-based radiology AI company, on March 2, 2026.
Show detailsHide details
The all-cash deal is valued at approximately €230 million, including €215 million at closing and a €15 million contingent milestone payment.
Gleamer will be integrated into RadNet's DeepHealth subsidiary, making DeepHealth the largest provider of radiology clinical AI solutions worldwide.
Gleamer serves over 700 customer contracts in 44 countries and achieved an ARR CAGR exceeding 90% from 2022 to 2025, with expected ARR of about $30 million in 2026.
The acquisition was disclosed under Item 7.01 Regulation FD, with the press release furnished as Exhibit 99.1.
7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
RadNet reports record Q4 2025 revenue and Adjusted EBITDA, issues 2026 guidance
Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in Q4 2025 from $477.1 million in Q4 2024.
Show detailsHide details
Total Company Adjusted EBITDA was a quarterly record of $87.7 million in Q4 2025, up 16.9% from $75.0 million in Q4 2024.
Adjusted Earnings Per Share was $0.23 for Q4 2025, compared with $0.24 for Q4 2024.
For full-year 2025, Total Company Revenue was $2,040.2 million and Adjusted EBITDA was $300.2 million.
2026 guidance anticipates Imaging Center segment Revenue growth of 17%-19%, Adjusted EBITDA growth of 18%-22%, and Free Cash Flow growth of 29%-41% from 2025 levels.
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits